Search
Search Constraints
You searched for: Author/Creator Thomas, StéphaneLimit your search
- Thomas, Stéphane [remove] 11
- 615.372 6
- Vaccines -- Periodicals 6
- 618.929 3
- Communicable diseases in children -- Periodicals 3
- Infection in children -- Periodicals 3
- 660.62 2
- Microbial biotechnology -- Periodicals 2
- Recombinant proteins -- Synthesis -- Periodicals 2
- AE adverse event(s) -- CI confidence interval -- D diphtheria toxoid -- DTaP5 diphtheria, tetanus, acellular pertussis (5-component) vaccine (Daptacel™) -- DTPa3-HB-IPV/Hib diphtheria, tetanus, acellular pertussis (3-component), inactivated polio, Haemophilus influenzae type b (PRP-T) vaccine (Infanrix™-hexa) -- DTaP5-HB-IPV-Hib diphtheria, tetanus, acellular pertussis (5-component), inactivated polio, Haemophilus influenzae type b (PRP-OMPC), and hepatitis B vaccine -- EU European Union -- FHA filamentous haemagglutinin -- FIM fimbriae types 2 and 3 -- GMC geometric mean concentration -- HBsAg hepatitis B surface antigen -- HepB hepatitis B vaccine (Recombivax HB™) -- Hib (PRP-OMPC) Haemophilus influenzae type b vaccine (polyribosylribitol phosphate-outer membrane protein conjugate) (PedvaxHIB™) -- Hib (PRP-T) Haemophilus influenzae type b vaccine (polyribosylribitol phosphate–tetanus toxoid conjugate) (ActHIB™) -- IPV inactivated polio vaccine -- PRN pertactin -- PT pertussis toxoid -- PCV13 pneumococcal conjugate vaccine, 13-valent (Prevnar 13™) -- RV1 rotavirus vaccine, monovalent (Rotarix™) -- RV5 rotavirus vaccine, 5-valent (RotaTeq™) -- T tetanus toxoid 1
- Co-administration -- DTaP-IPV-HB-PRP-T -- MenACWY-TT -- Immunogenicity -- Safety -- Booster vaccination 1